Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FRBU9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,883
Award facts
- Contract value 100% obligated
- $11,882.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $11,882.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 200-unit vials of Botox. The delivery order was awarded on November 10, 2025, with an ultimate completion date of December 3, 2025, and carries no set-aside designation, indicating the vendor competed in an unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for the Department of Defense.
DMS Pharmaceutical Group serves as a regional prime vendor contractor under the PPV-G GEN V program, which authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support military healthcare facilities worldwide. The company's primary indefinite delivery contract (SPE2DR) carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical supplier within the federal military medical supply chain. The vendor's established performance across numerous delivery orders for diverse pharmaceutical categories, including specialty products and biologics, demonstrates its capability to fulfill the specialized requirements of Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FRBU9?
SPE2DR26FRBU9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FRBU9 worth?
The government has obligated $11,883 on SPE2DR26FRBU9.
Is contract SPE2DR26FRBU9 an order under another contract?
Yes. SPE2DR26FRBU9 is a delivery order under SPE2DR25D9206, an indefinite delivery contract.
Was contract SPE2DR26FRBU9 competed?
The extent of competition for SPE2DR26FRBU9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award